IJPR  articles are Indexed in SCOPUS (2010 - 2021)Click Here     *Five Years Citation in Google scholar (2016 - 2020) is. 1451*        Now IJPR is Q2 in SJR Ranking     Scopus Coverage of IJPR (2010-2021 Issue 1)            

logo

INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH

A Step Towards Excellence

IJPR included in UGC-Approved List of Journals - Ref. No. is SL. No. 4812 & J. No. 63703

Published by : Advanced Scientific Research
ISSN
0975-2366
Current Issue
Article In Press
No Data found.
ADOBE READER

(Require Adobe Acrobat Reader to open, If you don't have Adobe Acrobat Reader)

Index Page 1
Click here to Download
IJPR 9[3] July - September 2017 Special Issue

July - September 9[3] 2017

Click to download
 

Article Detail

Label
Label
Repurposing of Drugs: Progress, development approaches and challenges

Author: RASANPREET KAUR, AKSHATA MANDLOI, SUDARSHAN SINGH LAKHAWAT, DESH DEEPAK SINGH, SUNIL KUMAR, VIKRAM KUMAR
Abstract: Drug repurposing approach is emerging to overcome the limitations of de novo drug discovery and development in fields of financial support, timeline and resources. Drug repositioning exploits the previously obtained clinical trials data for toxicity and adverse effects, and at the same time investigate the drug's therapeutic potential for another disease. Academia and research institutes, pharmaceutical companies and repurposing technology companies are the major key players in the field of drug repurposing. Various computational and experimental approaches help in the process of drug repurposing. An effective repurposing conduit involves the permutation of access to molecule data, suitable analytical skills to facilitate robust visions, expertise and experimental set up for validation, and clinical development. Compound identification arises from inspection of large libraries of active compounds, interrogating different databases or unifying several types of information regarding disease–drug correlations. In silico approaches like docking techniques evade the tedious in vitro and in vivo techniques implicated in former screening phases of the drugs and disease specific targets. However, there are various technological and regulatory challenges that need to be tackled.
Keyword: Drug repurposing, Clinical trials, Drug discovery, Safety, Efficacy
DOI: https://doi.org/10.31838/ijpr/2021.13.01.529
Download: Request For Article
 




ONLINE SUBMISSION
USER LOGIN


Username
Password
Login | Register
News & Events
SCImago Journal & Country Rank

Terms and Conditions
Disclaimer
Refund Policy
Instrucations for Subscribers
Privacy Policy

Copyrights Form

0.12
2018CiteScore
 
8th percentile
Powered by  Scopus
Google Scholar

hit counters free